Cargando…
Patients with Liver Cirrhosis Show High Immunogenicity upon COVID-19 Vaccination but Develop Premature Deterioration of Antibody Titers
SARS-CoV-2 infection is known to lead to severe morbidity and mortality in patients with liver cirrhosis. For this reason, vaccination of these patients against COVID-19 is widely recommended. However, data regarding immunogenicity in patients with liver cirrhosis is limited and even less is known a...
Autores principales: | Willuweit, Katharina, Frey, Alexandra, Passenberg, Moritz, Korth, Johannes, Saka, Nissrin, Anastasiou, Olympia E., Möhlendick, Birte, Schütte, Andreas, Schmidt, Hartmut, Rashidi-Alavijeh, Jassin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8949848/ https://www.ncbi.nlm.nih.gov/pubmed/35335009 http://dx.doi.org/10.3390/vaccines10030377 |
Ejemplares similares
-
Durability of Immune Response after Application of a Third Dose of SARS-CoV-2 Vaccination in Liver Transplant Recipients
por: Passenberg, Moritz, et al.
Publicado: (2023) -
Humoral Response to SARS-Cov-2 Vaccination in Liver Transplant Recipients–A Single-Center Experience
por: Rashidi-Alavijeh, Jassin, et al.
Publicado: (2021) -
Implications of anaemia and response to anaemia treatment on outcomes in patients with cirrhosis
por: Rashidi-Alavijeh, Jassin, et al.
Publicado: (2023) -
Standard coagulation tests are superior to thromboelastometry in predicting outcome of patients with liver cirrhosis
por: Rashidi-Alavijeh, Jassin, et al.
Publicado: (2020) -
Tiza–Titre increase and enhanced immunity through an adjuvanted, recombinant herpes zoster subunit vaccine in patients with liver cirrhosis and post-liver transplantation: a study protocol for a prospective cohort study
por: Vollmer-Raschdorf, Stephanie, et al.
Publicado: (2023)